Skip navigation Consumer Fund Healthcare Info & Comm Technology Internet & Digital Media

Helicos BioSciences

Helicos BioSciences is a life-science company committed to developing instruments and reagents for the high speed sequencing of single DNA and RNA molecules. High speed sequencing is a breakthrough tool for solving many important and difficult problems in biology and medicine. Helicos BioSciences’ technology will allow cancer researchers to fully and accurately characterize the cancer genome on tens of thousands of tumors, thereby elucidating the full range of molecular alterations which cause cancer, leading to a new era in cancer diagnosis and therapy.

Recent News

Helicos BioSciences Corporation Announces Pricing of Common Stock and Warrant Private Placement

Helicos Launches Open Access Web Site With Microbial Genome Data

Helicos BioSciences Reports Q3 2008 Financial Results

Steve Lombardi Named CEO of Helicos BioSciences Corporation

Helicos BioSciences Announces Collaboration with Children's Oncology Group to Elucidate Genomic Signatures in Ewing's Sarcoma

Helicos BioSciences Announces Shipment of the World's First Single Molecule DNA Sequencer

Helicos BioSciences Announces First Order for the Helicos(TM) Genetic Analysis Platform